PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1848387
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1848387
According to Stratistics MRC, the Global Water-Soluble and Powdered Supplement Market is accounted for $31.2 billion in 2025 and is expected to reach $68.1 billion by 2032 growing at a CAGR of 11.8% during the forecast period. Water-soluble and powdered supplement covers vitamins, minerals, protein powders, and functional blends formulated as powders or water-soluble sachets for easy consumption and absorption. Growth is propelled by health-conscious consumers, on-the-go lifestyles, and innovation in targeted formulations for immunity, performance, and recovery. E-commerce and direct-to-consumer models expand reach, while clean-label and personalized nutrition trends drive product development.
Rapid consumer interest in health & immunity
Rapid consumer interest in health and immunity is accelerating demand for water-soluble and powdered supplements, as more consumers seek convenient, science-informed ways to support daily wellness and resilience. This shift has prompted manufacturers to expand product lines with immune-focused vitamins, adaptogens, probiotics and fortified drink mixes while enhancing taste, solubility and bioavailability to boost adoption. E-commerce growth, subscription services and personalised nutrition platforms are widening reach and enabling targeted communication, and drive sustained category growth.
Stringent regulation and claims scrutiny
Stringent regulation and claims scrutiny constrain market expansion by raising compliance costs for manufacturers and increasing time-to-market for new formulations. Authorities in major markets demand scientific substantiation for health claims, transparent labeling, and adherence to safety thresholds for vitamins, minerals and botanicals, which forces firms to invest in third-party testing, clinical studies and robust quality management systems. Cross-border regulatory differences complicate launches and sometimes require reformulation, thereby slowing innovation. Consequently, smaller players may be excluded while consumers face limited choices and higher prices overall.
Expansion into emerging markets
Expansion into emerging markets represents a major growth opportunity as rising incomes, urbanisation and health awareness drive demand for preventive nutrition. Companies can localise formulations and flavours to match regional tastes, leverage growing modern retail and mobile commerce networks, and partner with local distributors to scale quickly. Additionally, affordability-focused formats such as single-serve sachets and value packs can unlock mass-market penetration, while co-branded programmes with healthcare professionals and tailored marketing will build trust, create repeat purchase behaviour and long-term loyalty globally.
High-profile recalls damaging consumer trust
High-profile recalls and contamination incidents pose a serious threat by eroding consumer trust and prompting regulatory crackdowns, which can shrink category demand and force costly corrective actions. Publicised mislabelling, undeclared allergens, or microbial contamination amplified on social media lead retailers to delist brands and trigger class-action litigation, increasing reputational and financial risk.
The COVID-19 pandemic reshaped demand and supply for water-soluble and powdered supplements: consumers rapidly purchased immunity and vitamin products, boosting short-term sales, while supply chains experienced ingredient shortages and manufacturing slowdowns. E-commerce and direct-to-consumer channels expanded as retail footfall fell, and regulators issued emergency guidance that sometimes accelerated approvals. Over time, heightened scrutiny and a shift toward clinically supported claims emerged, and companies adapted with resilient sourcing, inventory buffers and marketing.
The vitamins segment is expected to be the largest during the forecast period
The vitamins segment is expected to account for the largest market share during the forecast period. Vitamins benefit from broad clinical recognition and consumer familiarity, which makes them a primary entry point for powdered and water-soluble supplement consumption. Single vitamins such as vitamin D and vitamin C, along with multivitamin blends, address widespread nutritional gaps across ages and life stages, supporting sustained demand. Manufacturers favour vitamin formulations for their established regulatory pathways and predictable stability profiles, while innovation in delivery, flavour and bioavailability preserves growth momentum and support ongoing innovation.
The stick packs & sachets segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the stick packs & sachets segment is predicted to witness the highest growth rate. Single-serve stick packs and sachets align with on-the-go lifestyles, providing measured doses, minimal preparation and easy transport, which appeals to busy consumers and travellers. Their low unit cost, reduced packaging waste per serving and suitability for powdered drink mixes make them attractive for mass-market rollouts and sample promotions. Rising e-commerce and subscription services further enable trial and repeat purchases, and convenience.
During the forecast period, the North America region is expected to hold the largest market share. A mature health and wellness culture, high per-capita spending on dietary supplements and advanced retail infrastructure support strong market penetration for water-soluble and powdered formats. The region benefits from established contract manufacturers, rigorous quality standards and widespread third-party certification, which reassure consumers and retailers. Robust e-commerce, healthcare practitioner endorsement and sports nutrition demand further sustain category leadership and encourage innovation. Furthermore, sports nutrition demand and ageing populations will sustain premium formulation growth momentum.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. Rapid urbanisation, rising disposable incomes and greater health awareness among younger populations are accelerating acceptance of powdered and water-soluble supplements. Local manufacturers are innovating with region-specific botanicals and flavours while e-commerce platforms and modern trade channels enable wide distribution even in tier-two cities. Regulatory reforms and improved supply chain infrastructure are lowering barriers to entry, and cross-border exports are expanding as domestic quality standards climb. Additionally, strategic partnerships, affordable single-serve formats and targeted marketing to millennial consumers will drive penetration.
Key players in the market
Some of the key players in Water-Soluble and Powdered Supplement Market include Amway Corporation, Nestle Health Science, Abbott Laboratories, Bayer AG, Glanbia plc, Nature's Way Brands, LLC, OZiva, Herbalife Nutrition Ltd., NOW Foods, Otsuka Pharmaceutical Co., Ltd., Jarrow Formulas, Inc., Kemin Industries, Inc., Alltech, Inc., Cargill, Incorporated, Florida Supplement, L.L.C., Private Label Express USA, Robinson Pharma, Inc., Unilever PLC, Liquid I.V., and Olly Public Benefit Corporation.
In June 2025, Amway, the world's largest direct selling enterprise signaled its intention to grow its collaboration with South Korea-based HEM Pharma. This announcement follows a decade of groundbreaking collaboration between the companies since Amway first initiated research and collaboration with HEM in 2016. The companies have reinforced their shared commitment to advancing joint scientific research, technology, and services in the field of microbiome health across the more than 100 countries and territories where Amway conducts business.
In August 2024, Nestle Health Science and Seres Therapeutics, Inc. announced that they have signed an agreement in which Nestle Health Science will acquire the VOWST business. Nestle Health Science has been commercializing the VOWST (fecal microbiota spores, live-brpk) capsules since its launch in June 2023 in the United States. This transaction will allow Nestle Health Science full control over the further development, commercialization, and manufacturing of VOWST in the US and worldwide.
In March 2024, Japan's Otsuka Pharmaceutical opens new tab said it agreed to pay more than $1 billion to acquire Jnana Therapeutics as it looks to expand its drug pipeline and research base in the Boston area. Japan's Otsuka Pharmaceutical (4578.T), opens new tab said on Thursday it agreed to pay more than $1 billion to acquire Jnana Therapeutics as it looks to expand its drug pipeline and research base in the Boston area.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.